- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
As the COVID-19 coronavirus continues to spread, the markets took a beating on Monday due to uncertainty about its impact.
Fear surrounding the impact of more COVID-19 coronavirus cases is causing a depression in markets across the globe.
On Monday (February 24), the Dow Jones Industrial Average (INDEXDJX:.DJI) dropped over 1,000 points, or nearly 4 percent in value, as the world faced an increase in instances of the disease beyond its initial appearance in Wuhan, China.
The Dow closed Monday at 28,033.41 points, indicating a year-to-date loss of 1.74 percent.
“With stock prices and valuations still near cycle highs, the risk of a worsening virus outbreak has not been priced into the market to a great extent,” Keith Lerner, chief market strategist at Truist/SunTrust Advisory, told CNBC.
Similarly, the NASDAQ Biotechnology Index (INDEXNASDAQ:NBI), which tracks both the pharma and biotech public markets, dropped by 2.66 percent to close at 3,766.1 points on Monday.
The latest updates for the virus include heightening tension from countries like South Korea and Italy, where cases are rising. For the Asian nation, the disease is now a “red alert” threat at a national level. Besides China, South Korea is now the country with the highest recorded cases of the virus.
Italy has become the country with the fastest spreading of the virus outside of Asia, according to a report from the Washington Post.
Meanwhile, in China, 398 new cases and 149 more deaths were confirmed by officials in Hubei province.
According to a report from MarketWatch, the staggering drop on Monday for the Dow represents the first time in over a year that a 3 percent decline has been seen for this benchmark; it sank alongside the S&P 500 Index (INDEXSP:.INX) and the NASDAQ Composite Index (INDEXNASDAQ:.IXIC).
Companies in the life science space have been racing to find early stage treatments for the virus.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.